Artículos por temáticas

Effects of Hippeastrum reticulatum on memory, spatial learning and object recognition in a scopolamine-induced animal model of Alzheimer's disease

Hoang THX, Ho DV, Van Phan K, Le QV, Raal A, Nguyen HT.

Pharm Biol. 2020 Dec;58(1):1098-1104. doi: 10.1080/13880209.2020.1841810.

Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial

Devanand DP, Andrews H, Kreisl WC, Razlighi Q, Gershon A, Stern Y, Mintz A, Wisniewski T, Acosta E, Pollina J, Katsikoumbas M, Bell KL, Pelton GH, Deliyannides D, Prasad KM, Huey ED.

BMJ Open. 2020 Feb 6;10(2):e032112. doi: 10.1136/bmjopen-2019-032112.

A meta-analysis of the effect of binge drinking on the oral microbiome and its relation to Alzheimer's disease

Yussof A, Yoon P, Krkljes C, Schweinberg S, Cottrell J, Chu T, Chang SL.

Sci Rep. 2020 Nov 16;10(1):19872. doi: 10.1038/s41598-020-76784-x.

The approach and management of bruxism in Alzheimer's disease: An under-recognized habit that concerns caregivers (innovative practice)

Mathew T, Venkatesh S, Srinivas M.

Dementia (London). 2020 Feb;19(2):461-463. doi: 10.1177/1471301217694249. Epub 2017 Feb 15.

BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain

Sur C, Kost J, Scott D, Adamczuk K, Fox NC, Cummings JL, Tariot PN, Aisen PS, Vellas B, Voss T, Mahoney E, Mukai Y, Kennedy ME, Lines C, Michelson D, Egan MF.

Brain. 2020 Dec 1;143(12):3816-3826. doi: 10.1093/brain/awaa332.

Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial

Maier F, Spottke A, Bach JP, Bartels C, Buerger K, Dodel R, Fellgiebel A, Fliessbach K, Frölich L, Hausner L, Hellmich M, Klöppel S, Klostermann A, Kornhuber J, Laske C, Peters O, Priller J, Richter-S

JAMA Netw Open. 2020 May 1;3(5):e206027. doi: 10.1001/jamanetworkopen.2020.6027.

Statin Use and Risk of Cognitive Decline in the ADNI Cohort

Kemp EC, Ebner MK, Ramanan S, Godek TA, Pugh EA, Bartlett HH, McDonald JW, Mecca MC, van Dyck CH, Mecca AP; Alzheimer's Disease Neuroimaging Initiative.

Am J Geriatr Psychiatry. 2020 May;28(5):507-517. doi: 10.1016/j.jagp.2019.11.003. Epub 2019 Nov 11.

Multicenter Study on Sleep and Circadian Alterations as Objective Markers of Mild Cognitive Impairment and Alzheimer's Disease Reveals Sex Differences

Guarnieri B, Maestri M, Cucchiara F, Lo Gerfo A, Schirru A, Arnaldi D, Mattioli P, Nobili F, Lombardi G, Cerroni G, Bartoli A, Manni R, Sinforiani E, Terzaghi M, Arena MG, Silvestri R, La Morgia C, Di

J Alzheimers Dis. 2020;78(4):1707-1719. doi: 10.3233/JAD-200632.

The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer's Disease: The Okayama Depression and Apathy Project (ODAP)

Takemoto M, Ohta Y, Hishikawa N, Yamashita T, Nomura E, Tsunoda K, Sasaki R, Tadokoro K, Matsumoto N, Omote Y, Abe K.

J Alzheimers Dis. 2020;76(2):769-772. doi: 10.3233/JAD-200247.

Efficacy and safety of MAO-B inhibitor versus donepezil in Chinese elderly stroke patients with Alzheimer disease: A potential therapeutic option

Yang H, Han W, Li H.

Pak J Pharm Sci. 2020 May;33(3(Special)):1349-1354.

LW-AFC, a new formula from the traditional Chinese medicine Liuwei Dihuang decoction, as a promising therapy for Alzheimer's disease: Pharmacological effects and mechanisms

Cheng X, Huang Y, Zhang Y, Zhou W.

Adv Pharmacol. 2020;87:159-177. doi: 10.1016/bs.apha.2019.10.005. Epub 2020 Jan 3.

EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease

Khavinson V, Linkova N, Kozhevnikova E, Trofimova S.

Molecules. 2020 Dec 31;26(1):159. doi: 10.3390/molecules26010159.

Potential for Treatment of Neurodegenerative Diseases with Natural Products or Synthetic Compounds that Stabilize Microtubules

Miller JH, Das V.

Curr Pharm Des. 2020;26(35):4362-4372. doi: 10.2174/1381612826666200621171302.

[Pharmacological prevention of cognitive decline and dementia]

Jessen F.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 May;63(5):506-511. doi: 10.1007/s00103-020-03120-z.

Transcription factor NRF2 as a promising therapeutic target for Alzheimer's disease

Qu Z, Sun J, Zhang W, Yu J, Zhuang C.

Free Radic Biol Med. 2020 Nov 1;159:87-102. doi: 10.1016/j.freeradbiomed.2020.06.028. Epub 2020 Jul 28.